Estimating the Fiscal Consequences of National Immunization Programs Using a “Government Perspective” Public Economic Framework by Mark P. Connolly, Nikolaos Kotsopoulos

Get full text

Author Correction: Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow’s Milk Protein Allergy in the United Kingdom by Rui Martins, Mark P. Connolly, Eleanor Minshall

Get full text

Author Correction: Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow’s Milk Protein Allergy in the United Kingdom by Rui Martins, Mark P. Connolly, Eleanor Minshall

Get full text

Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow’s Milk Protein Allergy in the United Kingdom by Rui Martins, Mark P. Connolly, Eleanor Minshall

Get full text

Cost-effectiveness Analysis of Hypoallergenic Milk Formulas for the Management of Cow’s Milk Protein Allergy in the United Kingdom by Rui Martins, Mark P. Connolly, Eleanor Minshall

Get full text

The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium by Baudouin Standaert, Désirée Vandenberghe, Mark P. Connolly, Johan Hellings

Get full text

Assessing the Economic Burden and Benefit-cost of Treating Attention-deficit Hyperactivity Disorder in Germany by Nikolaos Kotsopoulos, Mark P. Connolly, Esther Sobanski, Maarten J. Postma

Get full text

The Hidden Economic Consequences of Migraine to the UK Government: Burden-of-Disease Analysis Using a Fiscal Framework by Rui Martins, Samuel Large, Rachel Russell, Gary Surmay, Mark P. Connolly

Get full text

Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis by Mark P. Connolly, Saswat Panda, Julien Patris, Bouke P. C. Hazenberg

Get full text

Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework by Mark P. Connolly, Nikos Kotsopoulos, Sebastian Vermeersch, Julien Patris, David Cassiman

Get full text

The public health and economic consequences of unintended pregnancies in South Africa by Hoa H. Le, Mark P. Connolly, Jingbo Yu, Yacob Pinchevsky, Petrus S. Steyn

Get full text

Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach. by Didik Setiawan, Nikolaos Kotsopoulos, Jan C Wilschut, Maarten J Postma, Mark P Connolly

Get full text

Managing Cow’s Milk Protein Allergy in Indonesia: A Cost-effectiveness Analysis of Hypoallergenic Milk Formulas from the Private Payers’ Perspective by Ana Teresa Paquete, Rui Martins, Mark P. Connolly, Badriul Hegar, Zakiudin Munasir, Stephanus Stephanus

Get full text

Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France by Ana Teresa Paquete, Rui Martins, Mark P. Connolly, Marie Meulle, Nítida Pastor, Grégoire Benoist, Patrick Tounian

Get full text

Public economic gains from tax-financed investments in childhood immunization in the United States. by Mark P Connolly, Nikolaos Kotsopoulos, Craig Roberts, Laurence Kotlikoff, David E Bloom, Tianyan Hu, Mawuli Nyaku

Get full text

Comparing the Fiscal Consequences of Controlled and Uncontrolled Osteoarthritis Pain Applying a UK Public Economic Perspective by Rui Martins, Nikos Kotsopoulos, Melodi Kosaner Kließ, Craig Beck, Lucy Abraham, Samuel Large, Patricia Schepman, Mark P. Connolly

Get full text

Comparing the Fiscal Consequences of Controlled and Uncontrolled Osteoarthritis Pain Applying a UK Public Economic Perspective by Rui Martins, Nikos Kotsopoulos, Melodi Kosaner Kließ, Craig Beck, Lucy Abraham, Samuel Large, Patricia Schepman, Mark P. Connolly

Get full text

Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability by Simon van der Schans, Marcel H. Schöttler, Jurjen van der Schans, Mark P. Connolly, Maarten J. Postma, Cornelis Boersma

Get full text

Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies by Svenn Alexander Kommandantvold, Nikos Kotsopoulos, Isabel Monteiro, Ana Ladeiras, Andrew Hogan, Felipe Barboza Magalhães de Araujo, Mark P. Connolly

Get full text

Identifying factors that can be used to assess a country’s readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: a scoping review by Samantha Vanderslott, Rebeccah Slater, Vaneesha Monk, Luke Baxter, Aomesh Bhatt, Natasha Hansen, Rachel Mitrovich, Amanda L Eiden, Alexandra Bhatti, Lindsay Hermany, Mark P Connolly

Get full text